Lexpos News

/Lexpos News

MHRA Drug Safety Update: August 2024

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 18 Issue 1 August 2024) has been published and includes articles on: Yellow Card Biobank: call to contribute to study of genetic links to side effects Letters and medicine recalls sent to healthcare professionals in July 2024. To see the latest MHRA [...]

The post MHRA Drug Safety Update: August 2024 appeared first on Community Pharmacy England.

By |August 21st, 2024|Lexpos News|Comments Off on MHRA Drug Safety Update: August 2024

NHS England extend use of NBS for flu vac

NHS England has announced, via an email message cascaded to pharmacy owners by ICBs, that they are offering use of the National Booking System (NBS) to all pharmacies that provide the Flu vaccination Advanced service. Previously, use of NBS to book flu vaccinations was only available to pharmacies that were also offering the COVID-19 vaccination [...]

The post NHS England extend use of NBS for flu vac appeared first on Community Pharmacy England.

By |August 21st, 2024|Lexpos News|Comments Off on NHS England extend use of NBS for flu vac

Pharmacy First myth busting series (#4)

This is the fourth of a series of articles to tackle some of the misconceptions around Pharmacy First. The articles will cover a variety of aspects of Pharmacy First and aims to myth bust, to increase understanding of the service. Patients with only certain minor illnesses can be electronically referred for the minor illness strand [...]

The post Pharmacy First myth busting series (#4) appeared first on Community Pharmacy England.

By |August 21st, 2024|Lexpos News|Comments Off on Pharmacy First myth busting series (#4)

MHRA Class 3 Medicines Recall: Fingolimod 0.5 mg Hard Capsules (Glenmark Pharmaceuticals Europe Ltd)

Class 4 Medicines Defect Information: Fingolimod 0.5 mg Hard Capsules (Glenmark Pharmaceuticals Europe Ltd) Drug alert number: EL (24)A/39 Date issued: 19 August 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Fingolimod 0.5 mg Hard Capsules (Glenmark Pharmaceuticals Europe Ltd) Company name: Glenmark Pharmaceuticals Europe [...]

The post MHRA Class 3 Medicines Recall: Fingolimod 0.5 mg Hard Capsules (Glenmark Pharmaceuticals Europe Ltd) appeared first on Community Pharmacy England.

By |August 19th, 2024|Lexpos News|Comments Off on MHRA Class 3 Medicines Recall: Fingolimod 0.5 mg Hard Capsules (Glenmark Pharmaceuticals Europe Ltd)

Pharmacy First myth busting series (#3)

This is the third of a series of articles to tackle some of the misconceptions around Pharmacy First. The articles will cover a variety of aspects of Pharmacy First and aims to myth bust, to increase understanding of the service. Patients who are electronically referred who have symptoms of a more serious illness/red flags should [...]

The post Pharmacy First myth busting series (#3) appeared first on Community Pharmacy England.

By |August 19th, 2024|Lexpos News|Comments Off on Pharmacy First myth busting series (#3)